2021 연구자 정보 (15 / 1141)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Kwon, Youngoh
(Kwon, Y)
GENOME INSIGHT Inc, Daejeon, South Korea

[JCR상위 0.7%] Clonal dynamics in early human embryogenesis inferred from somatic mutation SCIE 0.7 MULTIDISCIPLINARY SCIENCES ohjiwon@knu.ac.kr
ysju@kaist.ac.kr
Lee, Junehawk
(Lee, J)
Korea Inst Sci & Technol Informat KISTI, Daejeon, South Korea

[JCR상위 0.7%] Clonal dynamics in early human embryogenesis inferred from somatic mutation SCIE 0.7 MULTIDISCIPLINARY SCIENCES ohjiwon@knu.ac.kr
ysju@kaist.ac.kr
Liang, Qing
(Liang, Q)
NASA, Goddard Space Flight Ctr, Greenbelt, MD USA B-1276-2011
Liang, Qing
0000-0002-8430-0515
Liang, Qing
[JCR상위 0.7%] A decline in emissions of CFC-11 and related chemicals from eastern China SCIE 0.7 MULTIDISCIPLINARY SCIENCES Luke.western@bristol.ac.uk
rprinn@mit.edu
matt.rigby@bristol.ac.uk
Liau, Nicholas P. D.
(Liau, NPD)
Genentech Inc, Dept Struct Biol, San Francisco, CA 94080 USA HJI-9205-2023
Liau, Nicholas
0000-0002-3887-899X
Liau, Nicholas
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma SCIE 0.7 MULTIDISCIPLINARY SCIENCES twkimmd@amc.seoul.kr
shivam@gene.com
Lim, Hyeong-Seok
(Lim, HS)
Univ Ulsan, Asan Med Ctr, Dept Clin Pharmacol & Therapeut, Coll Med, Seoul, South Korea AAX-4732-2020
Lim, Hyeong-seok

[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma SCIE 0.7 MULTIDISCIPLINARY SCIENCES twkimmd@amc.seoul.kr
shivam@gene.com
Lim, Joonoh
(Lim, J)
Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn GSMSE, Daejeon, South Korea

[JCR상위 0.7%] Clonal dynamics in early human embryogenesis inferred from somatic mutation SCIE 0.7 MULTIDISCIPLINARY SCIENCES ohjiwon@knu.ac.kr
ysju@kaist.ac.kr
Lin, Eva
(Lin, E)
Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA

[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma SCIE 0.7 MULTIDISCIPLINARY SCIENCES twkimmd@amc.seoul.kr
shivam@gene.com
Malek, Shiva
(Malek, S)
교신저자 Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA

[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma SCIE 0.7 MULTIDISCIPLINARY SCIENCES twkimmd@amc.seoul.kr
shivam@gene.com
Manning, Alistair J.
(Manning, AJ)
Met Off, Hadley Ctr, Exeter, Devon, England

[JCR상위 0.7%] A decline in emissions of CFC-11 and related chemicals from eastern China SCIE 0.7 MULTIDISCIPLINARY SCIENCES Luke.western@bristol.ac.uk
rprinn@mit.edu
matt.rigby@bristol.ac.uk
Martin, Scott E.
(Martin, SE)
Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA

[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma SCIE 0.7 MULTIDISCIPLINARY SCIENCES twkimmd@amc.seoul.kr
shivam@gene.com
Modrusan, Zora
(Modrusan, Z)
Genentech Inc, Dept Microchem Prote & Lipid, San Francisco, CA 94080 USA

[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma SCIE 0.7 MULTIDISCIPLINARY SCIENCES twkimmd@amc.seoul.kr
shivam@gene.com
Montzka, Stephen A.
(Montzka, SA)
NOAA, Global Monitoring Lab, Boulder, CO USA V-6162-2019
montzka, stephen
0000-0002-9396-0400
Montzka, Stephen
[JCR상위 0.7%] A decline in emissions of CFC-11 and related chemicals from eastern China SCIE 0.7 MULTIDISCIPLINARY SCIENCES Luke.western@bristol.ac.uk
rprinn@mit.edu
matt.rigby@bristol.ac.uk
Moore, Amanda R.
(Moore, AR)
Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA

[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma SCIE 0.7 MULTIDISCIPLINARY SCIENCES twkimmd@amc.seoul.kr
shivam@gene.com
Noh, Young Su
(Noh, YS)
Hanmi Pharmaceut Co Ltd, Dept Clin Res & Dev, Seoul, South Korea

[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma SCIE 0.7 MULTIDISCIPLINARY SCIENCES twkimmd@amc.seoul.kr
shivam@gene.com
Nowicka, Malgorzata
(Nowicka, M)
Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA

[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma SCIE 0.7 MULTIDISCIPLINARY SCIENCES twkimmd@amc.seoul.kr
shivam@gene.com
페이지 이동: